Talk (300)

2006
Talk
Genzel, Y.; Reichl, U.: Limits and benefits of the interpretation of extracellular metabolite data in mammalian cell culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
Talk
Genzel, Y.; Sandig, V.; Jordan, I.: Neue Zellsubstrate und Einfluss von Medien und Prozessführung in der Impfstoffproduktion. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
Talk
Genzel, Y.; Schulze-Horsel, J.; Reichl, U.: High Cell Density Microcarrier Process in a Wave Bioreactor for the Production of Influenza A Virus. Vaccine Technology, Puerto Vallarta, Mexiko (2006)
Talk
Kalbfuss, B.; Gedicke, K.; Seidel-Morgenstern, A.; Reichl, U.: Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approach. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)
Talk
Kalbfuss, B.; Wolff, M. W.; Geisler, L.; Thom, V.; Reichl, U.: Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-Membranen. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
Talk
Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Best, C.; Morenweiser, R.; Reichl, U.: A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
Talk
Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Morenweiser, R.; Reichl, U.: Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
Talk
Reichl, U.: MDCK Cell Derived Influenza Vaccines: Aspects of Up- and Downstream Processing. Meeting Academy of Science, Sofia, Bulgarien (2006)
Talk
Reichl, U.: Dynamics of Influenza Virus Replication in Mammalian Cell Culture. CCEX Workshop, Vancouver, Canada (2006)
Talk
Reichl, U.: MDCK Cell derived Influenza Vaccines: Aspects of Modeling and Experimental Design in Upstream Processing. Meeting at Sanof Pasteur, Toronto, Canada (2006)
Talk
Reichl, U.: Biological Fundamentals, Models and Technologies for Vaccine Production. Perspectives of Research - Identification and Implementation of Research Topics by Organizations : Ringberg-Symposium Mai 2006, Kreuth, Germany (2006)
Talk
Reichl, U.: Mathematical Models for Mammalian Cell Growth and Virus Replication for an Influenza Vaccine Production Process. Technische Universität Berlin : Meeting, Berlin, Germany (2006)
Talk
Ritter, J. B.; Genzel, Y.; Reichl, U.: Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in Culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
Talk
Schulze-Horsel, J.; Bock, A.; Genzel, Y.; Reichl, U.: Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phase. GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
Talk
Wahl, A.; Nöh, K.; Wiechert, W.: Metabolic and Isotopic Instationary Experiments: A Simulative Study. Metabolic Engineering VI, Noordwijkerhout, The Netherlands (2006)
Talk
Wahl, S. A.; Nöh, K.; Wiechert, W.: Experiments at Metabolic and Isotopic Instationary State: An Exploratory study. Metabolic Engineering VI : From recDNA Towards Engineering Biological Systems, Noordwijkerhout, Netherlands (2006)
Talk
Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.: Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)
Talk
Wolff, M. W.; Kalbfuss, B.; Opitz, L.; Zimmermann, A.; Lehmann, S.; Reichl, U.: Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)
2005
Talk
Genzel, Y.; Schulze-Horsel, J.; Möhler, L.; Sidorenko, Y.; Reichl, U.: Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. 19th ESACT Meeting, Harrogate, UK (2005)
Talk
Heßeler, J.; Schmidt, J. K.; Reichl, U.; Flockerzi, D.: How to achieve coexistence in the chemostat: a combined mathematical and experimental approach. European Conference on Mathematical and Theoretical Biology (ECMTB), Dresden, Germany (2005)
Talk
Wolff, M.; Kalbfuss, B.; Morenweiser, R.; Zimmermann, A.; Reichl, U.: Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)
Talk
Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)
2004
Talk
Genzel, Y.; König, S.; Reichl, U.: Amino acid analysis in mammalian cell culture based virus vaccine production processes. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)
Talk
Rapp, E.; Lubda, D.; Seidel-Morgenstern, A.; Reichl, U.; Tallarek, U.: Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass Spectromety. 37. Diskussionstagung der Deutschen Gesellschaft für Massenspektrometrie, Leipzig, Germany (2004)

Poster (342)

2022
Poster
Dogra, T.; Pelz, L.; Marc, H.; Rüdiger, D.; Boehme, J.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)
Poster
Göbel, S.; Dorn, M.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. Vaccine Technology VIII, Sitges (Spain) (2022)
Poster
Göbel, S.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion mode. 27th ESACT Meeting, Lisbon (Portugal) (2022)
Poster
Göbel, S.; Kortum, F.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension cultures. Advancing Manufacture of Cell and Gene Therapies VII, Coronado, CA (USA) (2022)
Poster
Hellwig, P.; Dittrich, A.; Benndorf, D.; Reichl, U.: Establishment of a click chemistry-based method for detection and characterizationof phage-host systems in anaerobic digestion. 2nd German Phage Symposium, Stuttgart, Germany (2022)
Poster
Hellwig, P.; Heyer, R.; Maus, I.; Meinusch, N.; Walke, D.; Schlüter, A.; Hassa, J.; Sczyrba, A.; Klocke, M.; Mächtig, T. et al.; Schallert, K.; Seick, I.; Saake, G.; Reichl, U.; Benndorf, D.: Combined metagenomics and metaproteomics for analysis of the microbial community in a two-stage biogas plant. XIV Annual Congress of the European Proteomic Association, Leipzig, Germany (2022)
Poster
Hoang Son, T.; Lange, F.; Mahour, R.; Rexer, T.; Reichl, U.: In-vitro multi-enzyme cascades for the synthesis of UDP-galactose and UDP-N-acetylglucosamine. 32nd Joint Glycobiology Meeting, Utrecht, The Netherlands (2022)
Poster
Hoang Son, T.; Mahour, R.; Rexer, T.; Reichl, U.: In-vitro multi-enzyme cascades for the synthesis of UDP-galactose and UDP-N-acetylglucosamine. 10th International Congress on Biocatalysis (Biocat2022), Hamburg, Germany (2022)
Poster
Kupke, S. Y.; Hein, M.D.; Bdeir, N.; Rand, U.; Marichal-Gallardo, P.; Cicin-Sain, L.; Bruder, D.; Pöhlmann, S.; Schughart, K.; Reichl, U.: Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19. 31st Annual Meeting of the Society for Virology, online (2022)
Poster
Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F.G.; Genzel, Y.; Brooke, C.B.; Kupke, S. Y.; Reichl, U.: Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)
Poster
Pelz, L.; Rüdiger, D.; Dogra, T.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)
2021
Poster
Alcala Orozco, E. A.; Fiebig, T.; Mahour, R.; Grote, V.; Hoang Son, T.; Rexer, T.; Reichl, U.: A cell-free multi-enzyme cascade for the synthesis of CDP-glycerol. MECP2020+1 Conference, online (2021)
Poster
Pelz, L.; Rüdiger, D.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Semi-continuous propagation of influenza A virus and its defective interfering particles - analyzing the dynamic competition to select antiviral candidates. 30th Annual Meeting of the Society for Virology, online (2021)
Poster
Ruhnau, J.; Grote, V.; Juarez-Osorio, M.; Bruder, D.; Mahour, R.; Rapp, E.; Rexer, T.; Reichl, U.: Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein. glycoNET2021, virtually (2021)
2020
Poster
Kupke, S. Y.; Hein, M. D.; Kollmus, H.; Marichal-Gallardo, P.; Schughart, K.; Reichl, U.: The novel influenza A virus defective interfering particle "OP7" as an antiviral agent: discovery, production, and animal trials. The seventh ESWI Influenza Conference, Virtual Meeting (2020)
2019
Poster
Chuzel, L.; Ganatra, M.B.; Fossa, S.L.; Rapp, E.; Taron, C.: A functional metagenomics workflow for discovery of novel glycoside hydrolases. GlycoBioTec 2019, Berlin, Germany (2019)
Poster
Grote, V.; Cornean, A.; Hoffmann, M.; Thumberger, T.; Wittbrodt, J.; Reichl, U.; Rapp, E.: Embryonic Development in CDG Model Organism: Site-specific Glycoproteomic Analysis of O-Mannosylation in Oryzias Latipes. GlycoBioTec 2019, Berlin, Germany (2019)
Poster
Hanic, M.; McLeod, B.; Shi, S.; Rapp, E.; Hennig, R.; Lauc, G.; Trbojevic-Akmacic, I.: N-glycans sequencing using a novel exoglycosidase arry and xCGE-LIF analysis. GlycoBioTec 2019, Berlin, Germany (2019)
Poster
Hein, M.: Producing a new class of defective interfering particles as antiviral. 26th ESACT Meeting, Kopenhagen, Denmark (2019)
Poster
Hein, M.: Production of a novel class of influenza A virus-derived defective interfering particle as an antiviral agent. 14th PEACe, Rhode Island, USA (2019)
Poster
Hoffmann, M.; Pioch, M.; Pralow, A.; Hennig, R.; Kottler, R.; Reichl, U.; Rapp, E.: The Fine Art of Destruction: A Guide to In-Depth Glycoproteomic Analyses - Exploiting the Diagnostic Potential of Fragment Ions. GlycoBioTec 2019, Berlin, Germany (2019)
Poster
Kupke, S. Y.; Riedel, D.; Frensing, T.; Zmora, P.; Reichl, U.: A novel type of defective interfering particle for antiviral therapy. 26th ESACT Meeting, Copenhagen, Denmark (2019)
Poster
Pralow, A.; Hoffmann, M.; Pioch, M.; Hennig, R.; Nguyen-Khuong, T.; Genzel, Y.; Rapp, E.; Reichl, U.: Comprehensive N-glycosylation analysis of influenza A virus antigens derived from different production cell lines reveal immunogenic glycan epitopes. GlycoBioTec 2019, Berlin, Germany (2019)
Poster
Rexer, T.: Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Proteins by a Cell-Free, Compartmentalized Multi-Enzyme Cascade. GRC Carbohydrates, Hong Kong, China (2019)
Poster
Rodrigues Correia Ramos, J.; Bissinger, T.; Genzel, Y.; Reichl, U.: A Dynamic Model for Cell Growth, Metabolism & Virus Production of MDCK Suspension Cells. YCOPE 2019, Magdeburg, Germany (2019)
Poster
Rossdamm, C.; Konze , S.A.; Oberbeck, A.; Rapp, E.; Gerardy-Schahn, R.; von Itzstein, M.; Buettner, F.F.R.: xCGE-LIF as a novel approach for the analysis of glycoshingolipid-derived glycans. GlycoBioTec 2019, Berlin, Germany (2019)
Go to Editor View